Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
AHS 2021 consensus on integrating new migraine therapies into clinical practice: Isn't our goal choice of best therapy regardless of cost?
Journal: Headache
Published: September 06, 2021
Timing and durability of response to erenumab in patients with episodic migraine.
Journal: Headache
Published: April 01, 2021
Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
Journal: Journal of primary care & community health
Published: September 28, 2020
Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor.
Journal: Neurology and therapy
Published: September 23, 2020
Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials.
Journal: The journal of headache and pain
Published: April 01, 2020
Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN).
Journal: BMC neurology
Published: April 19, 2019
An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Journal: Headache
Published: September 10, 2013
A cross-sectional survey to assess the migraineur's medication decision-making beliefs: determining when a migraine is triptan-worthy.
Journal: Headache
Published: April 08, 2013
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
Journal: Journal of the neurological sciences
Published: January 25, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026